N. Masaki

发表

Anti‐gp210 and anti‐centromere antibodies are different risk factors for the progression of primary biliary cirrhosis

Masahiro Ito, K. Migita, H. Kondo, 2007, Hepatology.

Usefulness of elastometry in evaluating the extents of liver fibrosis in hemophiliacs coinfected with hepatitis C virus and human immunodeficiency virus.

S. Oka, N. Masaki, Y. Kikuchi, 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

Hepatitis B virus strains of subgenotype A 2 with an identical sequence spreading rapidly from the capital region to all over Japan in patients with acute hepatitis

E. Mita, T. Komeda, M. Nakamuta, 2017 .

Easy‐to‐use phylogenetic analysis system for hepatitis B virus infection

M. Nakanishi, M. Sugiyama, M. Mizokami, 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

Hepatitis B virus strains of subgenotype A2 with an identical sequence spreading rapidly from the capital region to all over Japan in patients with acute hepatitis B

E. Mita, H. Kohno, T. Komeda, 2011, Gut.

Hepatitis B virus strains of subgenotype A 2 with an identical sequence spreading rapidly from the capital region to all over Japan in patients with acute hepatitis B

E. Mita, H. Kohno, T. Komeda, 2022 .

Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals

N. Kato, H. Yoshida, M. Otsuka, 2021, Liver Cancer.

Pretreatment prediction of the outcome of response-guided peginterferon-α and ribavirin therapy for chronic hepatitis C

N. Enomoto, N. Izumi, T. Masaki, 2014, Journal of gastroenterology and hepatology.

Lower Th-1/Th-2 Ratio Before Interferon Therapy May Favor Long-Term Virological Responses in Patients with Chronic Hepatitis C

N. Masaki, S. Hayashi, S. Fukushima, 2002, Digestive Diseases and Sciences.

Cost-Outcome Description of PEG-IFN-α2b+RBV for Hepatitis C: Results Based on the Interferon Database.

H. Yamada, N. Masaki, Y. Kawasaki, 2017, Biological & pharmaceutical bulletin.

Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients

K. Migita, A. Komori, Yoko Nakamura, 2011, Journal of Gastroenterology.

Dynamic Epidemiology of Acute Viral Hepatitis in Japan

M. Mizokami, A. Komori, H. Ishibashi, 2010, Intervirology.

Appropriate use of virtual touch quantification and FibroScan® M and XL probes according to the skin capsular distance

M. Sugiyama, M. Mizokami, Sumio Watanabe, 2016, Journal of Gastroenterology.

Geographic distribution and characteristics of genotype A hepatitis B virus infection in acute and chronic hepatitis B patients in Japan

Y. Karino, M. Kurosaki, Y. Takikawa, 2016, Journal of gastroenterology and hepatology.

Risk factors for long‐term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults

Y. Karino, M. Kurosaki, Y. Takikawa, 2014, Hepatology.

Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C

H. Nomura, H. Yoshiji, N. Enomoto, 2014, Human Genetics.

Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease.

Hirokazu Takahashi, Y. Terauchi, H. Kirikoshi, 2009, Journal of hepatology.

Pretreatment serum levels of interferon-gamma-inducible protein-10 are associated with virologic response to telaprevir-based therapy.

M. Mizokami, T. Kanto, N. Masaki, 2016, Cytokine.

Deficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution

Y. Terauchi, A. Nakajima, Y. Nagashima, 2015, BMC Gastroenterology.

Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model

Y. Terauchi, A. Nakajima, Y. Nagashima, 2015, BMC Gastroenterology.

Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey

T. Saibara, K. Chayama, Y. Karino, 2016, Journal of Gastroenterology.

Factors improving the utility of antiviral therapy for chronic hepatitis B: A nationwide multicenter study in Japan

N. Masaki, Y. Yamagiwa, 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

Estimation of two real-time RT-PCR assays for quantitation of hepatitis C virus RNA during PEG-IFN plus ribavirin therapy by HCV genotypes and IL28B genotype

H. Nomura, M. Mizokami, N. Masaki, 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Increase in platelet count based on inosine triphosphatase genotype during interferon beta plus ribavirin combination therapy

H. Nomura, M. Mizokami, N. Masaki, 2012, Journal of gastroenterology and hepatology.

Usefulness of Magnetic Resonance Imaging for the Diagnosis of Hemochromatosis with Severe Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.

K. Hasuo, J. Akiyama, N. Masaki, 2016, Internal medicine.

Factors responsible for the discrepancy between IL28B polymorphism prediction and the viral response to peginterferon plus ribavirin therapy in Japanese chronic hepatitis C patients

H. Nomura, N. Enomoto, M. Kurosaki, 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

The rs8099917 Polymorphism, When Determined by a Suitable Genotyping Method, Is a Better Predictor for Response to Pegylated Alpha Interferon/Ribavirin Therapy in Japanese Patients than Other Single Nucleotide Polymorphisms Associated with Interleukin-28B

H. Nomura, M. Sugiyama, M. Mizokami, 2011, Journal of Clinical Microbiology.

Validation of the 3-day rule for stool bacterial tests in Japan.

N. Uemura, N. Masaki, C. Yokoi, 2014, Internal medicine.

Health state utilities of patients with hepatitis B and C and hepatitis-related conditions in Japan

S. Ikeda, T. Hirao, H. Yotsuyanagi, 2022, Scientific Reports.

Use of nucleoside analogs in patients with chronic hepatitis B in Nepal: A prospective cohort study in a single hospital

M. Sugiyama, M. Mizokami, N. Masaki, 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus

Sumio Watanabe, Nao Nishida, Hidekatsu Yanai, 2016, Journal of gastroenterology.

Association of serum IFN-λ3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection

H. Nomura, M. Kurosaki, N. Izumi, 2015, Journal of Gastroenterology.

An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

Alexander E. Lopez, Aaron M. King, Andrew L Blumenfeld, 2021, Journal of hepatology.

Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/Ribavirin therapy in chronic hepatitis C patients

M. Sugiyama, M. Mizokami, Sachiyo Yoshio, 2013, Journal of Gastroenterology.

Regional Differences in the Safety of Telaprevir-Based Triple Therapy for Chronic Hepatitis C in Japan:

N. Masaki, Hiroshi Yamada, Y. Kawasaki, 2018 .

Contribution of diuretic therapy with human serum albumin to the management of ascites in patients with advanced liver cirrhosis: A prospective cohort study.

M. Sata, Toru Nakamura, H. Moriwaki, 2014, Molecular and clinical oncology.

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

A. Koike, M. Honda, M. Kurosaki, 2009, Nature Genetics.

Risk Factors for Treatment Discontinuation Caused by Adverse Events When Using Telaprevir, Peginterferon, and Ribavirin to Treat Chronic Hepatitis C: A Real-World Retrospective Cohort Study.

N. Masaki, Y. Kawasaki, K. Ide, 2017, Biological & pharmaceutical bulletin.

The Safety Profile of Telaprevir-Based Triple Therapy in Clinical Practice: A Retrospective Cohort Study.

H. Yamada, N. Masaki, Y. Kawasaki, 2017, Biological and Pharmaceutical Bulletin.

Diffuse Liver Metastasis of Small-Cell Lung Cancer Presenting as Acute Liver Failure and Diagnosed by Transjugular Liver Biopsy: A Rare Case in Whom Nodular Lesions Were Detected by Enhanced CT Examination

Y. Egami, N. Masaki, C. Yokoi, 2015, Case Reports in Gastroenterology.

High-throughput and sensitive next-generation droplet digital PCR assay for the quantitation of the hepatitis C virus mutation at core amino acid 70.

Masaya Sugiyama, M. Sugiyama, M. Mizokami, 2014, Journal of virological methods.

Full-length sequence of hepatitis B virus belonging to genotype H identified in a Japanese patient with chronic hepatitis.

T. Sata, N. Masaki, A. Nakajima, 2005, Japanese journal of infectious diseases.

New Susceptibility and Resistance HLA-DP Alleles to HBV-Related Diseases Identified by a Trans-Ethnic Association Study in Asia

T. Ide, M. Honda, S. Kaneko, 2014, PloS one.

Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors.

N. Enomoto, M. Honda, S. Kaneko, 2011, Journal of hepatology.

Safety Profile of Telaprevir-Based Triple Therapy in Elderly Patients: A Real-World Retrospective Cohort Study.

H. Yamada, N. Masaki, Y. Kawasaki, 2017, Biological & pharmaceutical bulletin.

Bull Safety profile of telaprevir-based triple therapy in elderly patients : A real-world retrospective cohort study

H. Yamada, N. Masaki, Y. Kawasaki, 2017 .

Comparison of peginterferon alfa-2a and alfa-2b for treatment of patients with chronic hepatitis C: a retrospective study using the Japanese Interferon Database

T. Shimbo, N. Masaki, I. Sato, 2014, Drug design, development and therapy.

Contribution of Hepatitis C Virus Infection to the Development of Sjögren’s Syndrome in Japan

N. Masaki, S. Hayashi, S. Aotsuka, 1994 .

Acute hepatitis B in Japan: Incidence, clinical practices and health policy

H. Horiguchi, H. Yasunaga, H. Hashimoto, 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

The rs 8099917 Polymorphism , When Determined by a Suitable Genotyping Method , Is a Better Predictor for Response to Pegylated Alpha Interferon / Ribavirin Therapy in Japanese Patients than Other Single Nucleotide Polymorphisms Associated with Interleukin-28 B †

H. Nomura, M. Sugiyama, M. Mizokami, 2011 .

Acute Hepatitis C in HIV-1 Infected Japanese Cohort: Single Center Retrospective Cohort Study

S. Oka, Koji Watanabe, K. Tsukada, 2014, PloS one.

POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33

Y. Maehara, M. Honda, O. Yokosuka, 2019, Scientific Reports.

X chromosome contribution to the genetic architecture of primary biliary cholangitis.

Aaron M. King, Elizabeth G. Atkinson, K. Siminovitch, 2021, Gastroenterology.

A CASE OF MUCOSAL PROLAPSE SYNDROME MARKEDLY IMPROVED BY CONSERVATIVE TREATMENT

J. Akiyama, S. Yamato, N. Uemura, 2004 .

Early Duodenal Cancer at the Second Portion of the Duodenum : A Case Report

Ruriko Suzuki, S. Yamato, S. Tsurugano, 1993 .

Large spleno-caval shunt not accompanied by cirrhosis or encephalopathy

H. Imamura, Y. Harihara, K. Kurokawa, 1996, Journal of gastroenterology.

Marked clinical improvement in patients with hepatocellular carcinoma by surgical removal of extended tumor mass in right atrium and pulmonary arteries

T. Maruyama, N. Masaki, S. Hayashi, 2004, Cancer Chemotherapy and Pharmacology.

Genome‐wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population

Y. Maehara, K. Chayama, M. Honda, 2017, Human molecular genetics.

Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population.

Y. Maehara, M. Honda, S. Kaneko, 2012, American journal of human genetics.

Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis.

K. Migita, A. Komori, Yoko Nakamura, 2005, Journal of hepatology.

IL28B Polymorphisms and Clinical Implications for Hepatitis C Virus Infection in Uzbekistan

M. Sugiyama, M. Mizokami, N. Masaki, 2014, PloS one.

Characteristics of patients aged over 75 years with hepatitis C virus infection treated with direct‐acting antivirals in Japan: Evidence based on the nationwide, real‐world database in Japan

N. Masaki, Y. Nozaki, M. Yanase, 2020, Hepatology research : the official journal of the Japan Society of Hepatology.

Efficacy and safety of interferon treatment in elderly patients with chronic hepatitis C in Japan: A retrospective study using the Japanese Interferon Database

M. Mizokami, T. Shimbo, N. Masaki, 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

Regional disparities in interferon therapy for chronic hepatitis C in Japan: a nationwide retrospective cohort study

M. Mizokami, T. Shimbo, T. Kanto, 2015, BMC Public Health.

POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33

Y. Maehara, M. Honda, O. Yokosuka, 2019, Scientific Reports.

A thymine–adenine dinucleotide repeat polymorphism near IL28B is associated with spontaneous clearance of hepatitis C virus

J. Hayashi, M. Sugiyama, M. Mizokami, 2015, Journal of Gastroenterology.

Comparison of the Safety Profiles of Pegylated Interferon α-2a and α-2b Administered in Combination with Ribavirin for Chronic Hepatitis C Infection: A Real-World Retrospective Cohort Study.

H. Yamada, N. Masaki, I. Sato, 2016, Biological & pharmaceutical bulletin.

Scirrhous colonic metastasis from lobular carcinoma of breast

T. Ishida, M. Mizokami, Sumio Watanabe, 2013, Clinical Journal of Gastroenterology.

Quantification of collagen and elastic fibers using whole‐slide images of liver biopsy specimens

Tokiya Abe, Michiie Sakamoto, Akinori Hashiguchi, 2013, Pathology international.

Present state of hepatitis E virus epidemiology in Tokyo, Japan.

M. Hirano, N. Takeda, N. Masaki, 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis

T. Saibara, K. Chayama, Y. Karino, 2019, Journal of gastroenterology and hepatology.

Regional differences in hepatitis C treatment with peginterferon and ribavirin in Japan: a retrospective cohort study

Hiroshi Yamada, Kazuki Ide, Yohei Kawasaki, 2016, Drug design, development and therapy.

Nationwide survey on activities of regional core centers for the management of liver disease in Japan: Cumulative analyses by the Hepatitis Information Center 2009–2017

T. Kanto, N. Masaki, M. Korenaga, 2019, Hepatology research : the official journal of the Japan Society of Hepatology.

International collaborative survey on epidemiology of hepatitis E virus in 11 countries.

A. V. Smirnov, T. Sata, N. Takeda, 2006, The Southeast Asian journal of tropical medicine and public health.

Hepatitis B virus vaccination‐related seroprevalence among health‐care personnel in a Japanese tertiary medical center

M. Mizokami, N. Masaki, Y. Nozaki, 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

Effect of vitamin K2 on the recurrence of hepatocellular carcinoma

M. Kudo, N. Izumi, Y. Shiratori, 2011, Hepatology.

Drug-Drug Interactions in Patients Co-infected With HCV and HIV.

N. Masaki, Y. Nozaki, M. Yanase, 2015, JAMA.

Medication Adherence Among Patients With Chronic Hepatitis Receiving Antiviral Treatment

N. Yamamoto-Mitani, N. Masaki, A. Kawakami, 2019, Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates.

Regional Differences in Hepatitis C Treatment with Peginterferon and Ribavirin in Japan in Both Genotype 1 and Genotype 2: A Retrospective Cohort Study.

H. Yamada, N. Masaki, Y. Kawasaki, 2016, Biological & pharmaceutical bulletin.

TT Virus Infection Is Widespread in the General Populations from Different Geographic Regions

Y. Takebe, A. el-Zayadi, N. Masaki, 1999, Journal of Clinical Microbiology.

Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C

H. Nomura, H. Yoshiji, K. Ikeo, 2016, PloS one.

Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C

H. Nomura, H. Yoshiji, N. Enomoto, 2015, Human Genetics.

LecT‐hepa, a glyco‐marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients

M. Kurosaki, N. Izumi, A. Kuno, 2012, Hepatology.

Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]

Alexander E. Lopez, Aaron M. King, Andrew L Blumenfeld, 2021, Journal of hepatology.

Endoscopic submucosal dissection: a safe technique for colorectal tumors

E. Kogure, Yutaka Saito, N. Uemura, 2007, Endoscopy.

Regulating factors of liver regeneration after hepatectomy

N. Masaki, S. Hayashi, K. Fujiwara, 2004, Cancer Chemotherapy and Pharmacology.